School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK.
Ministry of Health, Muscat, Oman.
Int J Clin Pharm. 2023 Apr;45(2):342-354. doi: 10.1007/s11096-023-01534-8. Epub 2023 Jan 31.
Several guidelines support polypharmacy management in individual patients. More organisational-level focus is needed on the use of implementation frameworks.
To characterise the peer reviewed literature on implementation frameworks, focussing on barriers and facilitators to implementation at organisational level in the context of polypharmacy management.
A scoping review protocol was devised, supporting retrieval of studies published in English, reporting from any sector of practice. Medline, International Pharmaceutical Abstracts, Cumulative Index of Nursing and Allied Health Literature and Business Source Complete were searched to January 2022 using Medical Subject Headings including: 'polypharmacy', 'deprescriptions', 'strategic planning' and 'organizational innovation'. A narrative approach to data synthesis was applied. Searching, data extraction and synthesis were undertaken independently by two reviewers.
After screening 797 records eight papers remained. Two were descriptive outlining details of specific initiatives, six used qualitative methods to explore determinants for implementation including barriers and enablers. Organisation level barriers included: poor organisational culture with a lack of sense of urgency and national plans, resource availability and communication issues including patient information and at transitions of care. Organisational facilitators included availability of government funding and regulatory environment promoting patient safety, a national emphasis on quality of care for older adults, co-ordinated national efforts and local evidence.
Limited literature focusses on the use of implementation frameworks at organisational levels. This review highlights the need for further work on implementation frameworks in this context to help achieve effective organisational change.
有几项指南支持对个体患者进行多种药物治疗管理。需要更加关注组织层面的实施框架的使用。
描述在多种药物治疗管理背景下,针对组织层面实施障碍和促进因素的实施框架的同行评审文献。
设计了一个范围综述方案,检索发表在英语文献中、来自任何实践领域的报告。使用包括“多种药物治疗”、“减少用药”、“战略规划”和“组织创新”在内的医学主题词,从 2022 年 1 月起在 Medline、国际药学文摘、护理和联合健康文献累积索引以及商业来源完整数据库中进行检索。采用叙述性方法进行数据综合。两名评审员独立进行检索、数据提取和综合。
经过筛选 797 条记录,最终保留了 8 篇论文。其中 2 篇为描述性文章,概述了具体举措的细节,6 篇采用定性方法探讨了实施的决定因素,包括障碍和促进因素。组织层面的障碍包括:组织文化不佳,缺乏紧迫感和国家计划,资源可用性以及包括患者信息和护理交接在内的沟通问题。组织促进因素包括政府资金的可用性和促进患者安全的监管环境、国家对老年人护理质量的重视、协调的国家努力和本地证据。
有限的文献集中在组织层面实施框架的使用。本综述强调了在这方面进一步开展实施框架工作的必要性,以帮助实现有效的组织变革。